Jul. 31 at 5:00 PM
$QSI "does it have good fundamentals" — it doesn't, and won't until at least 2027 — but "do I believe Proteus ships on time, works as advertised, and finds enough labs willing to write
$425K checks." If yes, the current price is cheap. If Proteus slips two quarters or launches with disappointing amino-acid coverage, we are looking at a dilutive raise at a much lower price.
